Imunon

IMNN · NASDAQ

$1.01+$0.02 (+2.03%)TodayMarket closed ·
Prev close $0.985

About IMNN

The company is headquartered in Lawrenceville, New Jersey and currently employs 20 full-time employees.

Employees
20
Headquarters
Lawrenceville, New Jersey
Listed
Oct 27, 1993
Sector
Health Care
Industry
Biotechnology
Website
imunon.com

IMNN key statistics

Market cap
5.64M
Price-earnings ratio
0.00
Dividend yield
—
Average volume
119.56K
Volume
37.68K
Open price
$0.982
High today
$1.01
Low today
$0.98
52 Week high
$5.25
52 Week low
$0.96

Imunon (IMNN) at a glance

As of Oct 20, 2026, Imunon (IMNN) shares are priced at $1.01, giving the company a market cap of 5.64M and a price-to-earnings ratio of 0.00.

Today the stock has traded between $0.98 and $1.01. The current price is 2.6% above the day's low and 0.0% below its high.

Volume so far is 37.68K shares, below the average of 119.56K shares a day.

Over the past year Imunon has ranged from $0.96 to $5.25, and now sits 1% of the way up that range.

Imunon met or beat analyst EPS estimates in 7 of the last 8 quarters. In Q2 FY26 it reported -$0.54 per share against an estimate of -$0.9445.

The average analyst price target is $17.34, 1625.4% above the current price, from 1 recent ratings.

Analyst ratings

Latest rating from each analyst over the past 12 months

100%of 1 analyst rating say Buy
  • Buy100.0%
  • Hold0.0%
  • Sell0.0%
Price target · 7 analystsAvg $17.34
Low
$10.10
Now
$1.01
High
$26.25

IMNN earnings

Earnings per share, reported against the analyst estimate

Beat the estimate in 7 of the last 8 quarters, by 29.2% on average.

  1. Q3 FY24: reported -$4.43 per share against an estimate of -$5.29
  2. Q4 FY24: reported -$4.57 per share against an estimate of -$4.82
  3. Q1 FY25: reported -$3.65 per share against an estimate of -$4.66
  4. Q2 FY25: reported -$1.87 per share against an estimate of -$4.20
  5. Q3 FY25: reported -$1.16 per share against an estimate of -$1.84
  6. Q4 FY25: reported -$1.99 per share against an estimate of -$1.20
  7. Q1 FY26: reported -$0.84 per share against an estimate of -$1.13
  8. Q2 FY26: reported -$0.54 per share against an estimate of -$0.9445

IMNN news

  • Press releaseGlobe Newswire

    IMUNON Reports Second Quarter 2026 Financial Results and Provides Business Update

  • 12 Health Care Stocks Moving In Friday's After-Market Session

  • Vandana Singh

    EXCLUSIVE: Imunon Outlines Accelerated Timeline, Strong Safety Data for Pivotal Ovarian Cancer Study

  • Vandana Singh

    Exclusive: Imunon Says Lead Drug Continues To Show Promise in Advanced Ovarian Cancer Patients

  • Press releaseGlobe Newswire

    IMUNON to Present at the Life Sciences Investor Forum on June 25th

  • Press releaseGlobe Newswire

    IMUNON Reports First Quarter 2026 Financial Results and Provides Business Update

  • Press releaseGlobe Newswire

    IMUNON to Hold First Quarter 2026 Financial Results and Business Update Conference Call on Tuesday, May 12, 2026

  • 12 Health Care Stocks Moving In Tuesday's After-Market Session

Similar companies

Companies in the same industry as Imunon

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.